Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus

NCT02154347 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: KAD-1229
DRUG: Placebo
DRUG: Insulin

Sponsor

Kissei Pharmaceutical Co., Ltd.